FdaApplication
ANDA 209726
Identifiers
- fda_app_no: ANDA209726
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS CO GMBH |
| application_type | ANDA |
| approval_date | 2018-10-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM | 25MG;220MG | TABLET;ORAL |
1 product